Skip to main content

View Diary: Chart of the Day: The Coming Cancer Tsunami (4 comments)

Comment Preferences

  •  Cancer Immunotherapy (1+ / 0-)
    Recommended by:
    Roadbed Guy

     A relatively new attempt at controlling cancer is thru immunotherapy.  It was named the "Breakthrough of the Year" for 2013 by Science Magazine.

    http://www.sciencemag.org/...

    I am in a study of one of these drugs right now.  I had two surgeries foe melanoma a year ago, and was able to get into a Phase 3 trial of a drug that is supposed to boost the immune system of melanoma patients so we can fight the cancer ourselves.  

    The other options I had a year ago were to do nothing and hope they got it all via surgery or to get treatment with the drug interferon.  Interferon has a nasty side effect in people my age of giving you servere flu symptoms for the year you are on it.  It is also only marginally effective in reducing recurrence of melanoma.

    So the study I'm in will take for more years.  I don't know yet if I'm getting the real stuff or getting "sugar shots", but either way I'm getting great treatment at the U of Arizona Cancer Center, but here's hopin'.  

    "We borrow this Earth from our Grandchildren."

    by Arizona Mike on Tue Feb 04, 2014 at 03:00:39 PM PST

    •  That's very promising but a counter argument (0+ / 0-)

      is that there is a fundamental deficiency in a cancer patient's immune system that allowed the disease to progress in the first place.

      Therefore, in some proportion of patients boosting a defective immune system will not be all that helpful.  

      Nobody really knows what proportion of cancer patients fall into that category - here's to hoping that you're not one of them!   Because for some patients this is going to be really great.

      On the topic of this diary, it is difficult to see how this type of very expensive therapy is going to benefit the vast numbers of cancer patients predicted for developing nations.

Subscribe or Donate to support Daily Kos.

Click here for the mobile view of the site